CRB1 and Leber congenital amaurosis: Currently, there is no treatment available for CRB1-LCA patients, but proof-of-concept gene supplementation studies have shown functional rescue in CRB1 retinitis pigmentosa (RP) mouse models which sets a ground work for proof-of-concept in CRB1-LCA-like mouse models [272].